Copyright © 2024, Diaceutics. All rights reserved
About Us
At Diaceutics we believe that every patient should have access to the right treatment at the right time to positively impact their disease outcome, and we are committed to solving commercialization challenges.
We provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine through our platform
DXRX - The Diagnostic Network®
The Precision Medicine Webinar Series:
Strategies for Launch Success
In an increasingly competitive market, a data-driven and timely commercialization strategy is crucial to enable successful therapy and biomarker adoption.
The precision medicine industry is now in its fourth decade of clinical impact with significant progress continuing to be made, including the discovery of new biomarkers, treatments and testing methods. Despite technological and clinical advances, studies show that effective biomarker-driven approaches are still widely underutilized.
The perceived costs associated with launching new therapies are rising, placing a significant strain on resources available to pharma and biotechs. Diagnostic testing remains under-supported with many healthcare facilities lacking comprehensive genetic testing capabilities. This, coupled with a knowledge gap among physicians, can result in a significant proportion of eligible patients being lost along the treatment pathway.
Our webinar series provides insight into the opportunities which exist to overcome these limitations and the tactics and strategies pharma and biotech can deploy to achieve commercialization success.
NEXT WEBINAR NOVEMBER 13th, 1-2PM EST
NOVEMBER 13th, 1-2PM EST
Timely and effective engagement of physicians is critical in precision medicine. This webinar will showcase strategies for using data and omnichannel approaches to enhance engagement by rapidly identifying and educating physicians on your therapy in the commercial and clinical trial setting, ensuring timely therapy awareness that will help to drive therapy adoption and increase testing rates.
Cutting through the noise: Data-driven physician engagement in precision medicine
Gosia Leitch
VP, Engagement Solutions
Kelly Williams
VP, Insight Solutions
Harnessing real-world data for strategic provider targeting and early patient identification in precision medicine
As precision medicine continues to provide unique opportunities for patients, managing the growing volume of information continues to create challenges for pharma when implementing effective precision medicine programs. We now understand the importance of identifying biomarkers and engaging labs in the precision medicine journey, and the evolution of what we can do, and what we should do to ensure positive patient outcomes continues to grow. In this webinar, we will showcase the effectiveness of impactful scientific engagement on the clinical utility of this process.
DECEMBER 12th, 1-2PM EST
Ken Ruppel
VP, Scientific & Medical Services
Accelerate precision medicine uptake with impactful scientific engagement
How would insight into the current testing landscape for precision medicine benefit your commercialization strategy?
In this webinar series, learn how to:
Optimize therapy adoption by understanding the unique patient journey
Leverage real-world data to strategically position your therapy against competitors
Plan for commercial success by identifying opportunities to overcome market challenges and the tactics to deploy
Why watch?
- Understand how daily lab result data can quickly identify providers treating eligible patients for your therapy
- Discover the importance of engaging providers early in the treatment decision window to increase field team efficiencies and your message's impact
- Learn how to assess and score provider behaviors to inform the right resources to effectively engage your customers and close knowledge gaps, maximizing therapy adoption, capturing ROI and improving patient outcomes
Why join?
- Gain insight into how lab data can enable you to engage physicians within the critical treatment decision window driving biomarker testing rates
- Uncover the key challenges associated with reaching and engaging physicians and how digital communications can be a support to on-the-ground sales teams
- Understand the challenges in identifying the right audience of physicians to engage and how to reach physicians with rare biomarker patients efficiently
Why join?
- Learn the value of concordance studies in demonstrating the clinical utility of your precision medicine to physicians and how this can bolster testing uptake
- Understand the value of direct engagement with key labs to ensure every patient receives the most appropriate therapeutic options
- Discover how to utilize local experts within labs to amplify your precision medicine's share of voice
Driving commercial success for precision medicine: Understand the market to maximize patient identification & therapy adoption
Kevin Entwistle
VP, Precision Medicine Strategy Services
- Learn how to optimize therapy adoption by understanding the patient journey
- Discover how leveraging RWD allows you to strategically position against competitors
- Learn how to effectively structure your commercial plans for optimum success, utilizing Diaceutics' 6A™ Framework
Why watch?
Submit your details to watch this webinar and choose a convenient time to book your complementary 30-minute data strategy session with Kelly Williams